0.6701USD-2.53%Mkt Cap: 1.76M $P/E: —1d ago
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address un…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap1.76M $
Enterprise Value-2.88M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-7.15M $
Revenue/Share—
Last Price0.6701 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees9
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS00808Y3071
Valuation
P/E (Trailing)—
P/E (Forward)-1.34
PEG—
EV/EBITDA0.41
EV/Revenue—
P/S—
P/B0.22
EPS (TTM)-10.61
EPS (Forward)-0.50
52W Range
0.64000% of range27.40
52W High27.40 USD
52W Low0.6400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-146.36%
ROA-112.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.00M $
CapEx (TTM)3.70K $
FCF Margin—
FCF Yield-257.24%
Net Debt-4.51M $
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity0.07
Current Ratio3.85
Quick Ratio3.47
Book Value/Sh3.111 USD
Cash/Share2.120 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 15, 2019
Splits
Last Split1:10
Split DateOct 20, 2025
Analyst Consensus
Rating—
Target (Mean)3.250 USD
Upside (mean)+385.0%
Target Range1.500 USD – 5.000 USD
$1.500+385.0% to mean$5.000
# Analysts2
Ownership
Shares Out.2.63M
Float2.35M
Insiders5.15%
Institutions5.82%
Short Interest
Short Ratio0.7d
Short % Float9.24%
Short % Out.9.21%
Shares Short218.38K
Short (prev mo.)330.35K
Technical
SMA 501.730 (-61.3%)
SMA 2002.972 (-77.5%)
Beta1.41
S&P 52W Chg20.25%
Avg Vol (30d)240.91K
Avg Vol (10d)175.92K
Technical Indicators
RSI (14)24.0
MACD-0.3395
MACD Signal-0.3461
MACD Hist.+0.0066
BB Upper2.039 USD
BB Middle1.050 USD
BB Lower0.0614 USD
BB Width188.30%
ATR (14)0.1430 USD
Vol Ratio (20d)0.31x